Glucocorticoid-induced osteoporosis: an update on current pharmacotherapy and future directions

Author： Bultink Irene EM   Baden Marijke   Lems Willem F  

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.14, Iss.2, 2013-02, pp. : 185-197

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Osteoporosis in older persons: current pharmacotherapy and future directions

By Duque Gustavo  

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 14, 2013-10 ,pp. : 1949-1958

Informa Healthcare

Access to resources Recommend Favorite

Vitiligo: an update on current pharmacotherapy and future directions

By Colucci Roberta   Lotti Torello   Moretti Silvia  

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 13, 2012-09 ,pp. : 1885-1899

Informa Healthcare

Access to resources Recommend Favorite

Prevention of glucocorticoid-induced osteoporosis

By van Brussel MS   Bultink IEM   Lems WF  

Expert Opinion on Pharmacotherapy, Vol. 10, Iss. 6, 2009-04 ,pp. : 997-1005

Informa Healthcare

Access to resources Recommend Favorite

Primary Sjögren syndrome: an update on current pharmacotherapy options and future directions

By Brito-Zerón Pilar   Sisó-Almirall Antoni   Bové Albert   Kostov Belchin A   Ramos-Casals Manuel  

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 3, 2013-02 ,pp. : 279-289

Informa Healthcare

Access to resources Recommend Favorite

Mastocytosis: update on pharmacotherapy and future directions

By Cardet Juan Carlos   Akin Cem   Lee Min Jung  

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 15, 2013-10 ,pp. : 2033-2045

Informa Healthcare

Access to resources Recommend Favorite